PD-1 is not targeted for killing; PD-1 is downregulated on the CAR T cells to resist PD-1/PD-L1 inhibition. Cytotoxicity is directed against ROR1+ tumor cells via CAR-mediated T-cell killing, not PD-1–expressing cells.